StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

What Zhengye Biotechnology keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin20.5%
Operating margin-60.6%
EBITDA margin-38.3%
Pretax margin-61.8%
Net margin-60.0%
Free cash flow margin10.6%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-26.1%
Return on assets-15.0%
Return on invested capital-18.1%
Return on capital employed-22.3%

How hard the assets work

Revenue per dollar of assets0.25
Inventory turns a year1.90
Revenue per employeeCN¥2.28M
Profit per employee-CN¥1.37M

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by CN¥13.91M. That is 13.5% of the CN¥522.87M it would cost to buy the business outright.

Total debtCN¥65.80M
Cash and short-term investmentsCN¥51.89M
EBITDA, trailing twelve months-CN¥44.62M
Free cash flow, trailing twelve monthsCN¥12.33M

Leverage and liquidity

Debt to equity0.26
Debt to free cash flow5.34
Current ratio1.14
Quick ratio0.58

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

1.80
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-3.67
No flagManipulation risk

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-15.4%
Free cash flow yield2.73%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

49
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

ZYBTS&P 500
PeriodZYBTS&P 500DifferenceZYBT per yearS&P 500 per year
1 month+8.6%-4.0%+12.6 pts
3 months0.0%-5.0%+5.0 pts
Year to date+32.2%+8.2%+23.9 pts
1 year-30.4%+11.2%−41.7 pts

How much it moves

Volatility, 1 year1061.7%
Volume against its 90-day average0.00

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ZYBT shares were sold short on Oct 30, 2026, down 53.9% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 49.3% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back1.00

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202631,167-53.9%70,3121.0
Oct 15, 202667,594-41.3%3,118,1311.0
Sep 30, 2026115,090-16.1%20,5455.6
Sep 15, 2026137,172-21.1%37,7413.6
Aug 31, 2026173,858-52.0%247,2131.0
Aug 14, 2026362,103+22.0%8,911,3891.0
Jul 31, 2026296,924+417.6%19,111,5581.0
Jul 15, 202657,363+31.8%98,7361.0
Jun 30, 202643,518-59.8%20,7662.1
Jun 15, 2026108,354+265.5%327,7631.0
May 29, 202629,643-12.6%7,0974.2
May 15, 202633,909+7.9%99,4011.0

Every measure, in full

77 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
–

Valuation ratiosIndustry

Market Cap
CN¥452.09M
–
Enterprise Value
CN¥522.87M
–
PS Ratio
3.89
–
PB Ratio
1.81
–
P/TBV Ratio
2.23
–
P/FCF Ratio
36.68
–
P/OCF Ratio
33.91
–

Enterprise valuationIndustry

EV / Sales
4.49
–
EV / FCF
42.42
–

Share statisticsIndustry

Shares Change (YoY)
3.69%
3.69%
Float
4M
325M
Shares Held by Insiders
90.7%
19.6%

Short sellingIndustry

Short Interest
31,167
–
Short Interest Change
-53.9%
–
Days to Cover
1.00
–

Stock price statisticsIndustry

Price Change (1 Week)
-4.03%
–
Price Change (1 Month)
2.14%
–
Price Change (3 Months)
-6.54%
–
Price Change (6 Months)
54.9%
–
Price Change (YTD)
24.3%
–
Price Change (1 Year)
-33.5%
–
Average Volume (10 Days)
22,789
–
Average Volume (20 Days)
45,326
–
Average Volume (90 Days)
4M
–
Relative Volume
0.00
–
Relative Strength Index (14)
49.1
–
Volatility (1 Year)
1061.7%
–

MarginsIndustry

Gross Margin
20.5%
–
Pretax Margin
-61.8%
–
Profit Margin
-60.0%
–
EBITDA Margin
-38.3%
–
FCF Margin
10.6%
–

Returns on capitalIndustry

Return on Equity (ROE)
-26.1%
–
Return on Assets (ROA)
-15.0%
–
Return on Invested Capital (ROIC)
-18.1%
–
Return on Capital Employed (ROCE)
-22.3%
–

Financial positionIndustry

Current Ratio
1.14
–
Quick Ratio
0.58
–
Debt / Equity
0.26
–
Debt / FCF
5.34
–
Interest Coverage
-20.74
–

GrowthIndustry

Revenue Growth (YoY)
-37.6%
–
Net Income Growth (YoY)
-717.0%
–
FCF Growth (YoY)
-55.1%
–
Revenue Growth (3Y CAGR)
-23.5%
–

EfficiencyIndustry

Asset Turnover
0.25
–
Inventory Turnover
1.90
–
Revenue Per Employee
CN¥2.28M
–
Profits Per Employee
-CN¥1.37M
–
Employee Count
51
767

Income statement (TTM)Industry

Revenue
CN¥116.36M
–
Gross Profit
CN¥23.87M
–
Operating Income
-CN¥70.51M
–
Pretax Income
-CN¥71.87M
–
Net Income
-CN¥69.78M
–
EBITDA
-CN¥44.62M
–

Balance sheetIndustry

Total Debt
CN¥65.80M
–
Net Cash (Debt)
-CN¥13.91M
–
Net Cash Per Share
-0.29 CNY
–
Equity (Book Value)
CN¥249.85M
–
Book Value Per Share
5.27 CNY
–
Tangible Book Value
CN¥202.76M
–
Working Capital
CN¥16.94M
–

Cash flow (TTM)Industry

Operating Cash Flow
CN¥13.33M
–
Capital Expenditures
-CN¥1.01M
–
Free Cash Flow
CN¥12.33M
–
FCF Per Share
0.26 CNY
–

Dividends and yieldsIndustry

Earnings Yield
-15.4%
–
FCF Yield
2.73%
–

Taxes and interestIndustry

Interest Expense
CN¥3.40M
–
Income Tax
CN¥11.10M
–

Scores and fair valueIndustry

Altman Z-Score
1.80
–
Piotroski F-Score
3
–
Beneish M-Score
-3.67
–

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?